Impact of the 17-Gene Genomic Prostate Score Assay on Low Risk Prostate Cancer Patients in the Veterans Health Care Administration

Autor: A Dash, Megan P. Rothney, R Salup, CE Ercole, P Febbo, J Hernandez, SC Mathur, MA Liss, MC Risk, O Efimova, JW Basler, B Denes, M Kemeter, M Garzotto, MP Porter, L Barrett, D Duchene, Julie Lynch, Jonathan L. Wright

Publikováno v: Value in Health. 19:A167

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::236070bcbff2689ae6ebf56d0e9eb537
https://doi.org/10.1016/j.jval.2016.03.1521

Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer.

Autor: Agrawal R; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA., Al-Hiyari S; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA., Hugh-White R; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA., Hromas R; Division of Hematology and Medical Oncology, Department of Medicine and the Mays Cancer Center, University of Texas Health-San Antonio, San Antonio, TX, USA., Patel Y; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA., Williamson EA; Division of Hematology and Medical Oncology, Department of Medicine and the Mays Cancer Center, University of Texas Health-San Antonio, San Antonio, TX, USA., Mootor MFE; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA., Gonzalez A; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA., Fu J; Department of Microbiology and Immunology, University of Texas Health-San Antonio, San Antonio, TX, USA., Haas R; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA., Jordan M; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA., Wickes BL; Department of Microbiology, Immunology, and Molecular Genetics, University of Texas, San Antonia, TC, USA., Mohammed G; Office of Health Informatics and Analytics, University of California-Los Angeles, Los Angeles, CA, USA., Tian M; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA., Doris MJ; Department of Urology, University of Texas Health-San Antonio, San Antonio, TX, USA., Jobin C; Departments of Medicine, Infectious Diseases and Immunology, and Anatomy and Cell Physiology, University of Florida, Gainesville, FL, USA., Wernke KM; Department of Chemistry, Yale University, New Haven, CT, USA; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Pan Y; Office of Health Informatics and Analytics, University of California-Los Angeles, Los Angeles, CA, USA., Yamaguchi TN; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA., Herzon SB; Department of Chemistry, Yale University, New Haven, CT, USA; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Boutros PC; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Department of Medical Biophysics, University of Toronto, Toronto, Canada., Liss MA; Department of Urology, University of Texas Health-San Antonio, San Antonio, TX, USA. Electronic address: liss@uthscsa.edu.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.

Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.

Autor: Liss MA; Department of Urology, University of Texas Health San Antonio, San Antonio, Texas., Zeltser N; Department of Human Genetics, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California., Zheng Y; Department of Biostatistics, Fred Hutchinson Cancer Center, Seattle, Washington., Lopez C; Department of Biostatistics, Fred Hutchinson Cancer Center, Seattle, Washington., Liu M; Department of Biostatistics, Fred Hutchinson Cancer Center, Seattle, Washington., Patel Y; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Institute of Precision Health, University of California Los Angeles, Los Angeles, California., Yamaguchi TN; Department of Human Genetics, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Institute of Precision Health, University of California Los Angeles, Los Angeles, California., Eng SE; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California., Tian M; Department of Human Genetics, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Institute of Precision Health, University of California Los Angeles, Los Angeles, California., Semmes OJ; Department of Microbiology and Molecular Cell Biology, Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, Virginia., Lin DW; Division of Public Health Sciences, Department of Urology, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington., Brooks JD; Department of Urology, Stanford University, Palo Alto, California., Wei JT; Department of Urology, University of Michigan, Ann Arbor, Michigan., Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Tewari AK; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York., Mosquera JM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Robinson BD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Aasad M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Troyer DA; Department of Microbiology and Molecular Cell Biology, Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School, Norfolk, Virginia.; Department of Pathology, University of Texas Health San Antonio, San Antonio, Texas., Kagan J; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland., Sanda MG; Department of Urology, Emory University, Atlanta, Georgia., Thompson IM; The Children's Hospital of San Antonio Foundation and Christus Health, San Antonio, Texas., Boutros PC; Department of Human Genetics, University of California Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Institute of Precision Health, University of California Los Angeles, Los Angeles, California.; Department of Urology, University of California Los Angeles, Los Angeles, California., Leach RJ; Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, Texas.; Department of Pediatrics, University of Texas Health San Antonio, San Antonio, Texas.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Nov 01; Vol. 33 (11), pp. 1500-1511.

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.

Autor: Newcomb LF; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Urology, University of Washington, Seattle., Schenk JM; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Zheng Y; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Liu M; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Zhu K; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Brooks JD; Department of Urology, Stanford University, Stanford, California., Carroll PR; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., Dash A; Department of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington., de la Calle CM; Department of Urology, University of Washington, Seattle., Ellis WJ; Department of Urology, University of Washington, Seattle., Filson CP; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.; Department of Urology, Kaiser Permanente, Los Angeles, California., Gleave ME; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Liss MA; Department of Urology, University of Texas Health Sciences Center, San Antonio., Martin F; Department of Urology, Eastern Virginia Medical School, Virginia Beach., McKenney JK; Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Morgan TM; Department of Urology, University of Michigan, Ann Arbor., Tretiakova MS; Department of Pathology, University of Washington, Seattle., Wagner AA; Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Lin DW; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Urology, University of Washington, Seattle.

Publikováno v: JAMA [JAMA] 2024 Jun 25; Vol. 331 (24), pp. 2084-2093.

Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules.

Autor: Liss MA; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Dursun F; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Hackman GL; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA., Gadallah MI; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA.; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt., Saha A; Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Friedman CA; Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA., Rathore AS; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA., Chandra P; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA., White JR; Resphera Biosciences, USA., Tiziani S; Department of Nutritional Sciences, College of Natural Science, The University of Texas at Austin, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, 78723, USA.; Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, 78723, USA., DiGiovanni J; Division of Pharmacology & Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, 78723, USA.; Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, 78723, USA.; Center for Molecular Carcinogenesis and Toxicology, The University of Texas at Austin, Austin, TX, USA.

Publikováno v: Journal of traditional and complementary medicine [J Tradit Complement Med] 2024 Mar 07; Vol. 14 (5), pp. 558-567. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).